Brief: Sedana Medical Submits Application For Market Approval For Sedaconda For Inhaled Sedation In Intensive Care In UK

Sedana Medical AB (publ)

19/02/2021 12:36

Feb 19 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * HAS SUBMITTED AN APPLICATION FOR MARKET APPROVAL FOR DRUG
CANDIDATE SEDACONDA (ISOFLURANE) FOR INHALED SEDATION IN
INTENSIVE CARE IN UK.
    * SEDANA MEDICAL EXPECTS AN APPROVAL IN EU DURING SECOND
HALF OF
2021

Source text for Eikon:  ID:nWkr8T7PyX 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))